Clinical Trial Update: Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy of VB-111 in advanced differentiated thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• VB-111

Snippet

Sponsor: Vascular Biogenics Ltd. operating as VBL Therapeutics | Conditions: Differential Thyroid Cancer | Phase 2 | Status: COMPLETED